#311 — Did SARS-CoV-2 Escape from a Lab?

#311 — Did SARS-CoV-2 Escape from a Lab?

Up next

#478 — The Psychedelic Mind

Sam Harris speaks with Robin Carhart-Harris about psychedelic research and its therapeutic potential. They discuss the current state of the field, the FDA denial of MDMA-assisted therapy for PTSD, the critical role of set and setting, risks for vulnerable populations, the REBUS m ...  Show more

#477 — More From Sam: Iran's Unraveling, The Gaza Information War, AI-Generated Music, and More

Warning: This episode contains graphic descriptions of violence against civilians during the October 7 attacks (33:49 - 34:35). Listener discretion is advised. In this latest episode of the More From Sam series, Sam and Jaron talk about current events. They discuss the Trump admi ...  Show more

Recommended Episodes

Covid leaks and conspiracies
BBC Inside Science

Science writer Philip Ball has followed the relationship between government and its scientific advisors throughout the pandemic. He discusses the role of scientific advisors in the light of conflicting information following the leak of a number of former Health Minister Matt Hanc ...  Show more

Cristina Mejia Visperas, "Skin Theory: Visual Culture and the Postwar Prison Laboratory" (NYU, 2022)
New Books in Critical Theory

An abolitionist approach to STS and the history of the life sciences: this is the model that Cristina Mejia Visperas offers in her book, Skin Theory: Visual Culture and the Postwar Prison Laboratory (NYU 2022). By now, scientists’ experiments on captive men at Philadelphia’s Holm ...  Show more

Linking violence in Myanmar to fossil amber research, and waking up bacterial spores
Science Magazine Podcast

On this week’s show: A study suggests paleontological research has directly benefited from the conflict in Myanmar, and how dormant bacterial spores keep track of their environment First up on the podcast this week, Staff Writer Rodrigo Pérez Ortega joins host Sarah Crespi to dis ...  Show more

CRISPR & bioethics
Unexpected Elements

In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ...  Show more